Ultimovacs is a pharmaceutical company developing novel immunotherapies against cancer.
Read more about Ultimovacs
To extend and improve the life of patients by directing the immune system against the core of cancer.
We will provide universally accessible solutions.
Ultimovacs is developing a universal cancer vaccine applicable across a broad spectrum of cancer types.
Lead product tested in three clinical trials, strong results justifies the initiation of a registration trial.
